Healthy Extracts Acquires Precision-Dosed Nutraceutical Gummy Technology Innovator and Manufacturer, Gummy USA
Healthy Extracts (OTCQB:HYEX) has acquired Gummy USA, a Florida-based precision-dosed nutraceutical gummies manufacturer, in an all-stock transaction. The acquisition brings HACCP, GMP-certified, and FDA-registered manufacturing in-house, with production capacity scalable to $20 million in annual revenue.
The deal is projected to generate up to $7 million in additional annualized revenue in 2025, with the company expecting to reach an overall annualized revenue run rate exceeding $11.5 million by year-end. Gummy USA founder Don Swanson has been appointed president and chairman, while Duke Pitts continues as CEO.
The strategic acquisition adds a third specialized product marketing channel alongside existing gel-packs and functional drinking straws, enhancing vertical integration and expanding the company's IP portfolio. The facility is expected to generate $3.5 million in revenue in H2 2025, with potential to reach full capacity in 2026.
Healthy Extracts (OTCQB:HYEX) ha acquisito Gummy USA, un produttore della Florida specializzato in integratori nutraceutici in formato gummy a dosaggio preciso, tramite una transazione interamente in azioni. L'acquisizione consente di integrare internamente la produzione certificata HACCP, GMP e registrata FDA, con una capacità produttiva scalabile fino a 20 milioni di dollari di fatturato annuo.
L'accordo prevede un incremento fino a 7 milioni di dollari di ricavi annualizzati aggiuntivi nel 2025, con l'azienda che si aspetta di raggiungere un tasso di ricavi annualizzati complessivi superiore a 11,5 milioni di dollari entro fine anno. Il fondatore di Gummy USA, Don Swanson, è stato nominato presidente e chairman, mentre Duke Pitts rimane CEO.
Questa acquisizione strategica aggiunge un terzo canale di marketing specializzato per i prodotti, affiancando gli attuali gel-pack e cannucce funzionali, migliorando l'integrazione verticale e ampliando il portafoglio di proprietà intellettuale dell'azienda. Si prevede che la struttura genererà 3,5 milioni di dollari di ricavi nella seconda metà del 2025, con potenzialità di raggiungere la piena capacità nel 2026.
Healthy Extracts (OTCQB:HYEX) ha adquirido Gummy USA, un fabricante de gomitas nutracéuticas de dosificación precisa con sede en Florida, mediante una transacción completamente en acciones. La adquisición incorpora la fabricación interna certificada por HACCP, GMP y registrada por la FDA, con una capacidad de producción escalable hasta 20 millones de dólares en ingresos anuales.
Se proyecta que el acuerdo genere hasta 7 millones de dólares en ingresos adicionales anualizados para 2025, y la compañía espera alcanzar una tasa de ingresos anualizados total superior a 11,5 millones de dólares para fin de año. El fundador de Gummy USA, Don Swanson, ha sido nombrado presidente y chairman, mientras que Duke Pitts continúa como CEO.
La adquisición estratégica añade un tercer canal especializado de comercialización de productos junto con los actuales gel-packs y pajillas funcionales, mejorando la integración vertical y ampliando la cartera de propiedad intelectual de la empresa. Se espera que la planta genere 3,5 millones de dólares en ingresos en la segunda mitad de 2025, con potencial para alcanzar la capacidad total en 2026.
Healthy Extracts (OTCQB:HYEX)는 플로리다에 기반을 둔 정밀 용량 영양 보조 젤리 제조업체인 Gummy USA를 전액 주식 거래로 인수했습니다. 이번 인수로 HACCP, GMP 인증 및 FDA 등록된 제조 시설을 내부에 확보하게 되었으며, 연간 매출 2,000만 달러 규모로 생산 능력을 확장할 수 있게 되었습니다.
이번 거래는 2025년에 최대 700만 달러의 추가 연간 매출을 창출할 것으로 예상되며, 회사는 연말까지 총 연간 매출 실행률이 1,150만 달러를 초과할 것으로 기대하고 있습니다. Gummy USA 창립자 Don Swanson가 사장 겸 이사회 의장으로 임명되었으며, Duke Pitts는 CEO 직을 계속 유지합니다.
이번 전략적 인수는 기존의 젤팩 및 기능성 빨대와 함께 세 번째 전문 제품 마케팅 채널을 추가하여 수직 통합을 강화하고 회사의 지적 재산권 포트폴리오를 확장합니다. 이 시설은 2025년 하반기에 350만 달러의 매출을 창출할 것으로 예상되며, 2026년에는 최대 생산 능력에 도달할 가능성이 있습니다.
Healthy Extracts (OTCQB:HYEX) a acquis Gummy USA, un fabricant de gummies nutraceutiques à dosage précis basé en Floride, dans le cadre d'une transaction entièrement en actions. Cette acquisition intègre en interne une production certifiée HACCP, GMP et enregistrée auprès de la FDA, avec une capacité de production évolutive jusqu'à 20 millions de dollars de chiffre d'affaires annuel.
L'accord devrait générer jusqu'à 7 millions de dollars de revenus annuels supplémentaires en 2025, la société s'attendant à atteindre un chiffre d'affaires annuel global supérieur à 11,5 millions de dollars d'ici la fin de l'année. Le fondateur de Gummy USA, Don Swanson, a été nommé président et chairman, tandis que Duke Pitts reste CEO.
Cette acquisition stratégique ajoute un troisième canal de commercialisation spécialisé aux côtés des gel-packs et pailles fonctionnelles existants, renforçant l'intégration verticale et élargissant le portefeuille de propriété intellectuelle de l'entreprise. L'installation devrait générer 3,5 millions de dollars de revenus au second semestre 2025, avec un potentiel d'atteindre sa pleine capacité en 2026.
Healthy Extracts (OTCQB:HYEX) hat Gummy USA, einen in Florida ansässigen Hersteller von präzise dosierten nutraceutical Gummies, in einer reinen Aktientransaktion übernommen. Die Akquisition bringt HACCP-, GMP-zertifizierte und FDA-registrierte Produktion ins Unternehmen, mit einer Produktionskapazität, die auf 20 Millionen US-Dollar Jahresumsatz skalierbar ist.
Der Deal wird voraussichtlich bis zu 7 Millionen US-Dollar zusätzlichen Jahresumsatz im Jahr 2025 generieren, wobei das Unternehmen erwartet, bis Jahresende eine Gesamtjahresumsatzrate von über 11,5 Millionen US-Dollar zu erreichen. Der Gründer von Gummy USA, Don Swanson, wurde zum Präsidenten und Vorsitzenden ernannt, während Duke Pitts weiterhin CEO bleibt.
Die strategische Akquisition fügt neben den bestehenden Gel-Packs und funktionalen Trinkhalmen einen dritten spezialisierten Produktvertriebskanal hinzu, verbessert die vertikale Integration und erweitert das geistige Eigentumsportfolio des Unternehmens. Die Anlage soll in der zweiten Hälfte 2025 3,5 Millionen US-Dollar Umsatz erzielen, mit dem Potenzial, 2026 die volle Kapazität zu erreichen.
- Projected additional $7 million in annualized revenue for 2025
- In-house HACCP, GMP-certified, and FDA-registered manufacturing facility with $20M annual capacity
- Expected annualized revenue run rate exceeding $11.5M by year-end 2025 (4x growth from 2024)
- Addition of experienced leadership with Gummy USA founder as president and chairman
- Enhanced vertical integration with third product delivery system
- Potential for margin improvement through in-house manufacturing
- All-stock transaction structure may lead to shareholder dilution
- Significant capital commitment required for production scaling
- Integration risks with new manufacturing operations
- Currently listed on OTCQB market, pending uplist to national exchange
Transformative acquisition projected to generate up to an additional
$7 million in annualized revenue in 2025 and further expand bottom line.Brings HACCP, GMP-certified, and FDA-registered manufacturing in-house for the first time, with production capacity scalable to
$20 million in annual revenue and potential to reach full capacity in 2026.New white label and private label commercial customers that include premium brands and distributors.
Adds new oral delivery and proprietary manufacturing technology, with precision-dosed gummies that complement existing exclusive delivery systems of on-the-go gel packs and functional drinking straws.
LAS VEGAS, NV / ACCESS Newswire / July 29, 2025 / Healthy Extracts™ Inc. (OTCQB:HYEX), a leader in plant-based nutraceuticals targeting heart, brain, and gut health, has acquired Florida-based Gummy USA™, an advanced developer and manufacturer of precision-dosed nutraceutical gummies, in an all-stock transaction.
The strategic acquisition further builds out Healthy Extracts' vertical integration of R&D, manufacturing, marketing and distribution with a new fully in-house HACCP, GMP-certified and FDA-registered manufacturing facility.
Combined with the company's existing two exclusive delivery systems (gel-packs and functional drinking straws), the Gummy USA development and production platform unlocks a third specialized product marketing channel of precision-dosed nutraceutical gummies.
Based upon existing customer commitments and anticipated growth in order flow, the new Gummy USA unit is projected to generate up to
Health Extracts recently reiterated guidance of
The Gummy USA Florida manufacturing facility includes in-house R&D that is expected to further accelerate Healthy Extracts' overall product development, enhance already high margins, and substantially strengthen its IP portfolio.
The facility's new state-of-the-art manufacturing equipment was certified over the past year and is operated by highly trained production staff. Healthy Extracts has committed substantial funding to the new Gummy USA unit to support an anticipated increase in production and order fulfillment.
Representing a further strengthening of Healthy Extracts' management team and governance, Gummy USA founder, seasoned entrepreneur and manufacturing engineer, Don Swanson, has been appointed president and chairman of the board of Healthy Extracts. Duke Pitts will continue to serve as CEO and director.
Swanson is a recognized innovator in the fast-growing
"The transformative acquisition of Gummy USA accelerates our ability to bring clinically advanced products to market and drive strong revenue growth, as well as better position us for our planned uplist to a national exchange," stated Pitts. "We anticipate announcing major new customer wins over the coming weeks."
"As we continue to scale Healthy Extracts into a category-defining nutraceutical leader, this strategic acquisition adds more than just customers and manufacturing capacity, but more importantly, industry-leading expertise that has developed cutting-edge, proprietary production technology," added Pitts. "Don brings to us decades of experience and innovation in nutraceuticals and precision delivery systems, with this representing an exceptional value-add to our whole organization."
The acquisition also advances Healthy Extracts M&A strategy, which has included the successful acquisition BergametNA™ for heart health and Ultimate Brain Nutrients™ (UBN) for nootropic formulations-both supported by clinical research, patented formulations and proprietary manufacturing technologies.
The integration of Gummy USA's development and production capabilities will enable these two existing business units to more easily and cost-effectively develop and launch new products-such as the recently introduced Whitney Johns Gut Health Straw and Hydrate EZ and MYNUS Sugar Blocker gel-packs.
"We view this merger as representing the future of nutraceutical development and delivery," commented Swanson. "The combination and cross-pollination of our strong brands, experienced management, distribution networks, and visionary product roadmaps creates a powerful platform for rapid growth across our organizations. We see our combination also further supporting our mission of setting new standards for quality and innovation in the functional gummy industry."
"As now part of a public company with seasoned management experienced in the capital markets, we are already benefiting from more favorable access to growth capital that will enable us to more rapidly scale," added Swanson. "After an extensive search and evaluation process, we selected Healthy Extracts because of its favorable capital structure, with this supporting the ability of the combined companies to achieve a listing on a major exchange through growth and capitalization. We're very exciting about the future ahead."
You can learn more about the benefits of the acquisition in a video posted on the company's YouTube channel here.
Additional details related to the transaction are also available in a Form 8-K as filed by the company with the U.S. Security and Exchange Commission at www.sec.gov.
Don Swanson Bio
Don Swanson brings to Healthy Extracts nearly a decade of experience in pharmaceutical-grade manufacturing and gummy innovation. He has successfully designed and implemented state-of-the-art production facilities across multiple international regions where his proprietary processes have delivered unmatched manufacturing precision.
Under his visionary leadership, Gummy USA has secured multiple major customer orders while setting new industry standards for quality, regulatory compliance, and supply chain efficiency.
A recognized innovator in the nutraceutical and pharmaceutical gummy sectors, Swanson has developed extensive IP, including a patent portfolio related to the industry, and has managed global pharmaceutical enhancements for more than 500 clients.
His expertise spans automated controls, advanced fluid dynamics, and blockchain-enabled product authentication which have solved critical production inefficiencies while protecting brand integrity.
About Healthy Extracts
Healthy Extracts Inc. (OTCQB:HYEX) is a platform for acquiring, developing, patenting, marketing, and distributing plant-based nutraceuticals that deliver transformational health benefits. The company's subsidiaries, BergametNA™ and Ultimate Brain Nutrients™, offer clinically tested heart and brain health formulations.
BergametNA offers the only heart health supplement distributed in North America containing Citrus Bergamot SuperFruit™, a unique superfruit which has the highest known concentration of polyphenols and flavonoids.
The company holds exclusive IP on innovative delivery systems that include Gelteq gel-packs and the Gut Health Straw, both of which enable superior bioavailability and consumer convenience.
For more information visit: healthyextractsinc.com, bergametna.com or tryubn.com.
Forward-Looking Statements and Safe Harbor Notice
All statements other than statements of historical facts included in this press release are "forward-looking statements" (as defined in the Private Securities Litigation Reform Act of 1995). Such forward-looking statements include our expectations and those statements that use forward-looking words such as "projected," "expect," "possibility" and "anticipate." The achievement or success of the matters covered by such forward-looking statements involve significant risks, uncertainties and assumptions. Actual results could differ materially from current projections or implied results. Investors should read the risk factors set forth in the Company's Annual Report on Form 10-K filed with the SEC on April 1, 2025, and future periodic reports filed with the U.S. Securities and Exchange Commission (SEC). All of the Company's forward-looking statements are expressly qualified by all such risk factors and other cautionary statements. The Company cautions that statements and assumptions made in this news release constitute forward-looking statements and make no guarantee of future performance. Forward-looking statements are based on estimates and opinions of management at the time statements are made. The information set forth herein speaks only to the date hereof. The Company and its management undertake no obligation to revise these statements following the date of this news release.
Food & Drug Administration Disclosure
The product and formulation featured in this release is not for use by or sale to persons under the age of 12. This product should be used only as directed on the label. Consult with a physician before use if you have a serious medical condition or use prescription medications. A doctor's advice should be sought before using this and any supplemental dietary product. These statements have not been evaluated by the FDA. This product is not intended to diagnose, treat, cure or prevent any disease.
BergametNA™, Ultimate Brain Nutrients™, UBN™, Citrus Bergamot SuperFruit™ and F4T® are registered trademarks of Healthy Extracts Inc.™
Company Contact
Duke Pitts, President
Healthy Extracts Inc.
Tel (720) 463-1004
Email contact
Investor Contact
CMA Investor Relations
Tel (949) 432-7554
Email contact
SOURCE: HEALTHY EXTRACTS INC.
View the original press release on ACCESS Newswire
FAQ
What is the expected revenue impact of HYEX's acquisition of Gummy USA?
Who will lead Healthy Extracts (HYEX) after the Gummy USA acquisition?
What manufacturing capabilities does the Gummy USA acquisition bring to HYEX?
What is Healthy Extracts' (HYEX) projected revenue for 2025?
How does the Gummy USA acquisition fit into HYEX's business strategy?
